期刊文献+

苍艾挥发油对肺气虚大鼠肺组织病理形态和T细胞亚群的影响 被引量:5

The Effects of Cangai Volatile Oil on Pathological Change of Lung Tissue and T Lymphocyte Subtype in Lung Qi Deficiency Rats Model
原文传递
导出
摘要 目的探讨苍艾挥发油对肺气虚证大鼠的肺组织形态学及T细胞亚群的影响,以明确苍艾挥发油临床治疗肺气虚证的作用机制。方法复制大鼠肺气虚证模型,观察灌胃给药后大鼠肺组织形态学的变化并采用流式细胞仪检测T细胞亚群。结果苍艾挥发油高剂量组能有效地减少肺泡壁炎细胞的浸润,改善肺组织的充血状况,修复被破坏的黏膜组织。与模型对照组相比,苍艾挥发油高、中剂量组CD8+比例明显下降(P<0.05),差异有统计学意义,CD4+/CD8+比值较模型组显著升高,苍艾挥发油能有效调节肺气虚证大鼠全血中T淋巴细胞亚群的比例,使T淋巴细胞亚群的比例趋于平衡。结论苍艾挥发油灌胃给药,可以改善肺气虚大鼠肺组织病理变化,调节机体细胞免疫。 Objective The purpose of this study was to explore the effects of Cangai volatile oil( CVO) on pathological change and T lymphocyte subtype of Lung Qi deficiency rats model,so as to verify the treatment mechanism of CVO on the Lung Qi deficiency syndromes. Methods The Lung Qi deficiency rats model was built and pathological change and T lymphocyte subtype were detected. Results The high dosage of CVO could reduce the infiltration of inflammatory cells in the alveolar wall,improve the congestive position of lung tissue and repair damaged mucosa organizations. The CD4^+lymphocyte proportion of model groups is decline sharply compared with the normal group and showed statistically significant( P〈0. 05). The high and middle dosage of CVO could reduce the CD8^+lymphocyte proportion. efficiently regulate the T cell subsets' proportion to normal. Conclusion The administration gastric administration groups of high dosage with the dose of CVO can improve the congestive position of lung tissue and promote cell immune adjustment.
机构地区 云南中医学院
出处 《时珍国医国药》 CAS CSCD 北大核心 2015年第8期1845-1847,共3页 Lishizhen Medicine and Materia Medica Research
基金 国家自然科学基金地区基金项目(No.81160534)
关键词 苍艾挥发油 肺气虚证 T细胞亚群 Cangai volatile oil Lung Qi deficiency syndromes Tlymphocyte subtype
  • 相关文献

参考文献4

二级参考文献14

  • 1杨牧祥,李澎涛,韩树芬,方朝义,刘淑君,王占波,田元祥.实验性“肺气虚证”肺组织病理学研究[J].河北医科大学学报,1996,17(6):344-345. 被引量:34
  • 2沈自尹.中医虚证参考标准[J].中西医结合杂志,1986,6(10):598-598.
  • 3赵武达 陈仁 等.现代临床免疫学,第1版[M].北京:人民军医出版社,1994.1-3.
  • 4中华医学会呼吸分会.支气管哮喘定义诊断严重分级治疗判断标准(修订方案)[J].中华结核和呼吸杂志,1993,.
  • 5朱文锋.中医诊断学(第7版)[M].北京:中国中医药出版社,2003.182.
  • 6Schloss mzn SD, Bloumsell L, Giks W, et al. Leucocyte typing V: White cell differentiation antigens. New York :Oxford university press, 1995:89.
  • 7Farrar WL, Johnson HM, Farrar JJ. Regulation of the production of immune interferon and eytotoxle T lympheytes by interleukin2. J Immun, 1981; 126(3) :1120.
  • 8Henney CS, Kuribayashi K, Kern, et al. Interlenkin 2 augments natural killer cell activity.Nature, 1981 ;291(5813) :335.
  • 9罗任.中医虚证治疗手册[M].北京:人民军医出版社,1993.40.
  • 10武维屏,张立山.慢性肺原性心脏病因理症治探析[J].北京中医药大学学报,1997,20(6):57-58. 被引量:11

共引文献125

同被引文献102

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部